Sluijter ME et al. — The Anti-Inflammatory Action of Pulsed Radiofrequency — A Hypothesis and Potential Applications
Medical Sciences, September 2023
This paper — published posthumously in memory of Menno Sluijter, PRF's inventor — presents a comprehensive theoretical framework for understanding how PRF exerts systemic anti-inflammatory effects, and introduces the term RedoxPRF for this application.
The core hypothesis builds on the Brasil et al. (2020) rat study to propose a three-cycle model of cell stress: oxidative stress (cycle 1) triggers inflammation via NFκB activation (cycle 2), which in turn leads to immune tolerance and chronic inflammation (cycle 3). PRF is hypothesized to intervene at the most upstream point — reducing free radicals through radical pair recombination driven by PRF's magnetic field component, thereby breaking the self-reinforcing cycle before inflammation even develops.
Key findings:
- RedoxPRF works selectively on oxidative stress, targeting the root cause rather than downstream symptoms — positioning it as fundamentally different from both ablation and stimulation. The authors propose the term "functional restoration"
- Transcutaneous application (via skin electrodes) was validated as an effective alternative to earlier intravenous approaches, based on finite element modeling showing electromagnetic currents pass readily through blood vessel walls
- For systemic effect, intravascular immune cells are the proposed target, exposed to PRF fields as they circulate through a treated area
- The Sluijter-Teixeira-Poisson (STP) current — an irregular pulse variant — is introduced as a potentially more biologically effective waveform
Potential applications beyond pain include stroke, diabetes type 2, age-related macular degeneration, major depressive disorder, chronic kidney disease, COPD, osteoarthritis, post-infection fatigue, and stage 4 cancer.
Significance: This is the foundational theoretical paper for RedoxPRF as a distinct treatment modality.